{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:22:33Z","timestamp":1772270553902,"version":"3.50.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jaad.2021.03.108","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T21:01:21Z","timestamp":1618952481000},"page":"301-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests"],"prefix":"10.1016","volume":"85","author":[{"given":"Kelsey B.","family":"Nusbaum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham M.","family":"Korman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly H.","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica A.","family":"Kaffenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Trinidad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spero","family":"Cataland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin H.","family":"Kaffenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaad.2021.03.108_bib1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jaad.2015.08.072","article-title":"Coagulation disorders and their cutaneous presentations: pathophysiology","volume":"74","author":"Chang","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.03.108_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4103\/0019-5049.144643","article-title":"Overview of the coagulation system","volume":"58","author":"Palta","year":"2014","journal-title":"Indian J Anaesth"},{"key":"10.1016\/j.jaad.2021.03.108_bib3","series-title":"Transfusion Medicine and Hemostasis","first-page":"559","article-title":"Overview of the coagulation system","author":"Gil","year":"2019"},{"issue":"3","key":"10.1016\/j.jaad.2021.03.108_bib4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jaad.2013.01.043","article-title":"The skin and hypercoagulable states","volume":"69","author":"Thornsberry","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"20","key":"10.1016\/j.jaad.2021.03.108_bib5","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/archinte.161.20.2433","article-title":"Hypercoagulability syndromes","volume":"161","author":"Thomas","year":"2001","journal-title":"Arch Intern Med"},{"issue":"18","key":"10.1016\/j.jaad.2021.03.108_bib6","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa013383","article-title":"Skin ulcers misdiagnosed as pyoderma gangrenosum","volume":"347","author":"Weenig","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jaad.2021.03.108_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/11595240-000000000-00000","article-title":"Etiology and management of pyoderma gangrenosum: a comprehensive review","volume":"13","author":"Ahronowitz","year":"2012","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.03.108_bib8","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1016\/S2665-9913(20)30420-3","article-title":"COVID-19 vasculitis and novel vasculitis mimics","volume":"3","author":"McGonagle","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.03.108_bib9","doi-asserted-by":"crossref","first-page":"e500","DOI":"10.1097\/CCM.0000000000004917","article-title":"D-dimer and death in critically ill patients with coronavirus disease 2019","volume":"49","author":"Short","year":"2021","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.jaad.2021.03.108_bib10","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1161\/ATVBAHA.120.314872","article-title":"Prevalence and outcomes of d-dimer elevation in hospitalized patients with COVID-19","volume":"40","author":"Berger","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.jaad.2021.03.108_bib11","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.2215\/CJN.01480308","article-title":"D-dimer level and the risk for thrombosis in systemic lupus erythematosus","volume":"3","author":"Wu","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.jaad.2021.03.108_bib12","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1177\/1076029617736382","article-title":"The plasma levels of ADAMTS-13, von Willebrand factor, VWFpp, and fibrin-related markers in patients with systemic sclerosis having thrombosis","volume":"24","author":"Habe","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"10.1016\/j.jaad.2021.03.108_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/labmed\/lmw001","article-title":"Widely used types and clinical applications of D-dimer assay","volume":"47","author":"Riley","year":"2016","journal-title":"Lab Med"},{"issue":"3","key":"10.1016\/j.jaad.2021.03.108_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00001721-200204000-00010","article-title":"Decrease in sensitivity of D-dimer for acute venous thromboembolism after starting anticoagulant therapy","volume":"13","author":"Couturaud","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.108_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-3848(92)90155-4","article-title":"Effects of long-term treatment with warfarin on fibrinogen, FPA, TAT, and D-dimer in patients with coronary artery disease","volume":"66","author":"Eritsland","year":"1992","journal-title":"Thromb Res"},{"issue":"05","key":"10.1016\/j.jaad.2021.03.108_bib16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1055\/s-0037-1615530","article-title":"D-dimer and factor VIIa in atrial fibrillation: prognostic values for cardiovascular events and effects of anticoagulation therapy","volume":"115","author":"Siegbahn","year":"2016","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.jaad.2021.03.108_bib17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1553-2712.2010.00765.x","article-title":"Factors associated with positive D-dimer results in patients evaluated for pulmonary embolism","volume":"17","author":"Kabrhel","year":"2010","journal-title":"Acad Emerg Med"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.108_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archderm.1991.01680010085013","article-title":"Fibrin-and fibrinogen-related antigens in patients with venous disease and venous ulceration","volume":"127","author":"Falanga","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2021.03.108_bib19","doi-asserted-by":"crossref","first-page":"f2492","DOI":"10.1136\/bmj.f2492","article-title":"Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis","volume":"346","author":"Schouten","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jaad.2021.03.108_bib20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/jth.13976","article-title":"Subcommittee on Lupus Anticoagulant\/Antiphospholipid syndrome. Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH","volume":"16","author":"Devreese","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.jaad.2021.03.108_bib21","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis","volume":"7","author":"Pengo","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.jaad.2021.03.108_bib22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1160\/TH08-06-0410","article-title":"Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population","volume":"101","author":"Lambert","year":"2009","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.jaad.2021.03.108_bib23","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1365-2141.2000.02466.x","article-title":"The importance of locally\u00a0derived reference ranges and standardized calculation\u00a0of dilute Russell's viper venom time results in screening for lupus anticoagulant","volume":"111","author":"Gardiner","year":"2000","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.jaad.2021.03.108_bib24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1751-553X.2011.01376.x","article-title":"New guidelines for lupus anticoagulant: sensitivity and specificity of cut-off values calculated with plasmas from healthy controls in mixing and confirmatory tests","volume":"34","author":"Martinuzzo","year":"2012","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jaad.2021.03.108_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/983094","article-title":"Increased performances of the biological diagnosis of the antiphospholipid syndrome by the use of a multiplex assay","volume":"2015","author":"S\u00e9nant","year":"2015","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.108_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.thromres.2006.07.014","article-title":"Italian Federation of Anticoagulation Clinics (FCSA). Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-\u03b22-glycoprotein I activity","volume":"120","author":"Pengo","year":"2007","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.jaad.2021.03.108_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/rheumatology\/keh029","article-title":"Comparison of different kits in the detection of autoantibodies to cardiolipin and beta2glycoprotein 1","volume":"43","author":"Audrain","year":"2004","journal-title":"Rheumatol (Oxford)"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.108_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.33349","article-title":"International consensus guidelines on anticardiolipin and anti\u20132-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies","volume":"64","author":"Lakos","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.108_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.autrev.2013.08.007","article-title":"Autoantibody profiling of patients with antiphospholipid syndrome using an automated multiplexed immunoassay system","volume":"13","author":"Tozzoli","year":"2014","journal-title":"Autoimm Rev"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.108_bib30","doi-asserted-by":"crossref","first-page":"e000107","DOI":"10.1136\/lupus-2015-000107","article-title":"Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE","volume":"3","author":"Domingues","year":"2016","journal-title":"Lupus Sci Med"},{"issue":"2","key":"10.1016\/j.jaad.2021.03.108_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.jaad.2021.03.108_bib32","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/jth.14261","article-title":"Identification of\u00a0high thrombotic risk triple-positive antiphospholipid syndrome\u00a0patients is dependent on anti-cardiolipin and anti-\u03b22glycoprotein I antibody detection assays","volume":"16","author":"Chayoua","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.jaad.2021.03.108_bib33","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1160\/TH04-12-0839","article-title":"Antibody profiles for the diagnosis of antiphospholipid syndrome","volume":"93","author":"Pengo","year":"2005","journal-title":"Thromb Haemost"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2021.03.108_bib34","first-page":"S75","article-title":"Antiphospholipid syndrome: laboratory testing and diagnostic strategies","volume":"87","author":"Ortel","year":"2012","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.jaad.2021.03.108_bib35","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pathol.2018.11.008","article-title":"Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negatives","volume":"51","author":"Favaloro","year":"2019","journal-title":"Pathology"},{"issue":"2","key":"10.1016\/j.jaad.2021.03.108_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.autrev.2016.12.010","article-title":"Detection of lupus anticoagulant in the era of direct oral anticoagulants","volume":"16","author":"Hoxha","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.108_bib37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.thromres.2008.11.017","article-title":"A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study","volume":"124","author":"Toulon","year":"2009","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.jaad.2021.03.108_bib38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MBC.0000000000000806","article-title":"Comparison of clot-based and chromogenic assay for the determination of protein C activity","volume":"30","author":"Roshan","year":"2019","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jaad.2021.03.108_bib39","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620912028","article-title":"Laboratory limitations of excluding hereditary protein C deficiency by chromogenic assay: discrepancies of phenotype and genotype","volume":"26","author":"Seidel","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"issue":"5","key":"10.1016\/j.jaad.2021.03.108_bib40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00001721-200007000-00008","article-title":"Screening for abnormalities of the protein C anticoagulant pathway using the ProC global assay. Results of a european multicenter evaluation","volume":"11","author":"Toulon","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"11","key":"10.1016\/j.jaad.2021.03.108_bib41","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.5858\/2002-126-1349-AROTTD","article-title":"A review of the technical, diagnostic, and epidemiologic considerations for protein S assays","volume":"126","author":"Goodwin","year":"2002","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"10.1016\/j.jaad.2021.03.108_bib42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0049-3848(97)00179-5","article-title":"Evaluation of a new screening assay ProC Global for identification of defects in the protein C\/protein S anticoagulant pathway","volume":"87","author":"Ruzicka","year":"1997","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.jaad.2021.03.108_bib43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000081509","article-title":"Normal functional protein S activity does not exclude protein S deficiency","volume":"33","author":"Rodger","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"6","key":"10.1016\/j.jaad.2021.03.108_bib44","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1182\/blood.V95.6.1935","article-title":"Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S","volume":"95","author":"Makris","year":"2000","journal-title":"Blood"},{"issue":"04","key":"10.1016\/j.jaad.2021.03.108_bib45","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1055\/s-0037-1615062","article-title":"A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen","volume":"79","author":"Giri","year":"1998","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.jaad.2021.03.108_bib46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/ijlh.12219","article-title":"Laboratory testing issues for protein C, protein S, and antithrombin","volume":"36","author":"Marlar","year":"2014","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"10.1016\/j.jaad.2021.03.108_bib47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/jth.14667","article-title":"Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH","volume":"18","author":"Cooper","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.jaad.2021.03.108_bib48","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.5858\/2002-126-1337-LIIDAO","article-title":"Comp P. Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor","volume":"126","author":"Kottke-Marchant","year":"2002","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.108_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ijlh.12004","article-title":"Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis","volume":"35","author":"Mackie","year":"2013","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.108_bib50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2141.1994.tb04999.x","article-title":"Further evidence that activated protein C resistance can be misdiagnosed as inherited functional protein S deficiency","volume":"88","author":"Cooper","year":"1994","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jaad.2021.03.108_bib51","first-page":"257","article-title":"Utility of testing for factor V Leiden","volume":"10","author":"Franchini","year":"2012","journal-title":"Blood Transfus"},{"issue":"7","key":"10.1016\/j.jaad.2021.03.108_bib52","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archinte.166.7.729","article-title":"Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review","volume":"166","author":"Ho","year":"2006","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.jaad.2021.03.108_bib53","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1055\/s-0039-1694772","article-title":"Genetic testing for thrombophilia-related genes: observations of testing patterns for factor V Leiden (G1691a) and prothrombin gene \u201cMutation\u201d(G20210A)","volume":"45","author":"Favaloro","year":"2019","journal-title":"Sem Thromb Hemost"},{"issue":"10","key":"10.1016\/j.jaad.2021.03.108_bib54","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/EBP.0000000000000636","article-title":"In patients with an unprovoked deep venous thrombosis, what is the clinical utility of testing for FVL and prothrombin G20210A mutations compared with no testing at all?","volume":"23","author":"Henderson","year":"2020","journal-title":"Evidence-Based Pract"},{"issue":"3","key":"10.1016\/j.jaad.2021.03.108_bib55","first-page":"255","article-title":"Factor V Leiden: to test or not to test, that is the debate","volume":"10","author":"Makris","year":"2012","journal-title":"Blood Transfus"},{"issue":"8","key":"10.1016\/j.jaad.2021.03.108_bib56","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/ejhg.2010.33","article-title":"Usefulness of factor V Leiden mutation testing in clinical practice","volume":"18","author":"Blinkenberg","year":"2010","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"10.1016\/j.jaad.2021.03.108_bib57","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMra1700365","article-title":"Thrombophilia testing and venous thrombosis","volume":"377","author":"Connors","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jaad.2021.03.108_bib58","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/adc.2010.199919","article-title":"Purpura fulminans: recognition, diagnosis and management","volume":"96","author":"Chalmers","year":"2011","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.jaad.2021.03.108_bib59","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/ajcp\/86.5.653","article-title":"Protein C antigen deficiency and warfarin necrosis","volume":"86","author":"Rose","year":"1986","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.jaad.2021.03.108_bib60","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2168.2000.01352.x","article-title":"Warfarin induced skin necrosis","volume":"87","author":"Chan","year":"2000","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.jaad.2021.03.108_bib61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2141.2008.07339.x","article-title":"Does thrombophilia testing help in the clinical management of patients?","volume":"143","author":"Middeldorp","year":"2008","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.jaad.2021.03.108_bib62","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.21037\/jtd.2016.12.40","article-title":"Utility of thrombophilia testing in patients with venous thrombo-embolism","volume":"8","author":"Kudo","year":"2016","journal-title":"J Thorac Dis"},{"issue":"23","key":"10.1016\/j.jaad.2021.03.108_bib63","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1001\/jama.2009.853","article-title":"Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review","volume":"301","author":"Segal","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jaad.2021.03.108_bib64","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0190-9622(99)70434-2","article-title":"Monoclonal gammopathies and associated skin disorders","volume":"40","author":"Daoud","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.03.108_bib65","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1373\/clinchem.2009.126664","article-title":"Screening panels for detection of monoclonal gammopathies","volume":"55","author":"Katzmann","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.jaad.2021.03.108_bib66","series-title":"Online Curricula: Onco-Nephrology","article-title":"Ch 8: clinical tests for monoclonal proteins","author":"Leung","year":"2016"},{"key":"10.1016\/j.jaad.2021.03.108_bib67","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clinbiochem.2017.05.001","article-title":"Laboratory testing for monoclonal gammopathies: focus on monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"51","author":"Willrich","year":"2018","journal-title":"Clin Biochem"},{"issue":"12","key":"10.1016\/j.jaad.2021.03.108_bib68","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis\u00a0of\u00a0multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.108_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-9-11","article-title":"Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure","volume":"9","author":"Hutchison","year":"2008","journal-title":"BMC Nephrol"},{"issue":"3","key":"10.1016\/j.jaad.2021.03.108_bib70","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1373\/clinchem.2008.117143","article-title":"Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine","volume":"55","author":"Palladini","year":"2009","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.jaad.2021.03.108_bib71","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1373\/clinchem.2006.069104","article-title":"Serum free light chains: an\u00a0alternative to the urine Bence Jones proteins screening test\u00a0for monoclonal gammopathies","volume":"52","author":"Hill","year":"2006","journal-title":"Clin Chem"},{"issue":"5","key":"10.1016\/j.jaad.2021.03.108_bib72","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins. A report of 86 cases","volume":"57","author":"Brouet","year":"1974","journal-title":"Am J Med"},{"issue":"4-5","key":"10.1016\/j.jaad.2021.03.108_bib73","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.autrev.2014.01.027","article-title":"The diagnosis and classification of the cryoglobulinemic syndrome","volume":"13","author":"Damoiseaux","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2021.03.108_bib74","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-008102","article-title":"Cryofibrinogenaemia: not just skin deep","volume":"2013","author":"Sandouk","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.jaad.2021.03.108_bib75","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.revmed.2014.09.007","article-title":"Cryofibrinogenemia: a single-center study at the University Hospital of Toulouse, France","volume":"36","author":"Michaud","year":"2015","journal-title":"Revue Med Interne"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.108_bib76","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1258\/acb.2009.009180","article-title":"Cryoglobulin evaluation: best practice?","volume":"47","author":"Sargur","year":"2010","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"10.1016\/j.jaad.2021.03.108_bib77","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1373\/clinchem.2007.090134","article-title":"A critical appraisal of current practice in the detection, analysis, and reporting of cryoglobulins","volume":"54","author":"Vermeersch","year":"2008","journal-title":"Clin Chem"},{"issue":"12","key":"10.1016\/j.jaad.2021.03.108_bib78","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1016\/S0021-9258(19)70707-8","article-title":"Study of the kinetic and structural properties of a monoclonal immunoglobulin G cryoglobulin","volume":"255","author":"Scoville","year":"1980","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.jaad.2021.03.108_bib79","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.amjmed.2003.09.033","article-title":"An approach to the diagnosis and treatment of cryofibrinogenemia","volume":"116","author":"Amdo","year":"2004","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.jaad.2021.03.108_bib80","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5858\/1999-123-0119-EOC","article-title":"Evaluation of cryoglobulins","volume":"123","author":"Kallemuchikkal","year":"1999","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.jaad.2021.03.108_bib81","first-page":"395","article-title":"Cryoglobulins: an important but neglected clinical test","volume":"36","author":"Shihabi","year":"2006","journal-title":"Ann Clin Lab Sci"},{"issue":"6","key":"10.1016\/j.jaad.2021.03.108_bib82","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/clinchem\/38.6.798","article-title":"Characterization of cryoglobulins by immunoblotting","volume":"38","author":"Musset","year":"1992","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.jaad.2021.03.108_bib83","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/elps.1150090303","article-title":"Cryoglobulinemia: analysis of isotype, idiotype and antibody activity by composite gel electrophoresis and immunoblotting","volume":"9","author":"Chu","year":"1988","journal-title":"Electrophoresis"},{"issue":"9","key":"10.1016\/j.jaad.2021.03.108_bib84","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.amjmed.2015.02.017","article-title":"Cryoglobulinemia vasculitis","volume":"128","author":"Cacoub","year":"2015","journal-title":"Am J Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221006812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221006812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:57:39Z","timestamp":1759273059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962221006812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0190962221006812"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2021.03.108","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.03.108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(21)01954-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}